RxDoctor Payments DataLook up a doctor →

Andrew Braunstein, DO

Neurology · Mooresville, NCNPI 1457343337

Payments from drug & device makers

$251,997in general payments, 2019–2025

Across 1,907 payments — averaging $132.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$56K
  • SK Life Science, Inc.$54K
  • AbbVie$40K
  • H. Lundbeck A S$16K
  • UCB SA$14K
  • Neurelis, Inc.$13K
  • plus $57K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen93$56,483
SK Life Science, Inc.110$54,382
AbbVie(2 entities)241$39,907
H. Lundbeck A S9$16,261
UCB SA3$13,948
Neurelis, Inc.66$13,345
Idorsia Pharmaceuticals US Inc14$11,090
Eisai Inc.40$8,653
Avanir Pharmaceuticals, Inc.31$6,244
MDD US Operations, LLC58$4,926
Teva Pharmaceuticals USA, Inc.200$2,327
Supernus Pharmaceuticals, Inc.39$1,831
Sunovion Pharmaceuticals Inc.4$1,342
Biogen73$1,245
Inspire Medical Systems, Inc.12$1,242
Novartis76$1,224
UCB, Inc.66$1,208
Genentech, Inc.1$1,140
Bristol Myers Squibb26$1,043
Lundbeck LLC53$969
Sanofi50$968
Jazz Pharmaceuticals Inc.52$818
TG Therapeutics, Inc.24$775
Lilly USA, LLC41$708
Acadia Pharmaceuticals Inc36$665
EMD Serono, Inc.27$631
Takeda Pharmaceuticals U.S.A., Inc.26$563
AstraZeneca(2 entities)24$533
Pfizer46$530
Neurocrine Biosciences, Inc.27$511
Argenx US, Inc.16$451
Merz Pharmaceuticals, LLC16$386
Amneal Pharmaceuticals LLC20$319
Harmony Biosciences LLC14$310
Greenwich Biosciences, Inc.13$307
Genentech USA, Inc.15$303
Adamas Pharmaceuticals, Inc.13$265
Biohaven Pharmaceuticals, Inc.27$264
Avadel CNS Pharmaceuticals, LLC10$231
Axsome Therapeutics, Inc.9$229
Acorda Therapeutics, Inc11$224
Biohaven Pharmaceutical Holding Company Ltd.20$216
Impel Pharmaceuticals LLC9$183
Upsher-smith Laboratories LLC8$155
GE HealthCare10$155
Grifols USA, LLC8$154
Kyowa Kirin, Inc.6$134
Corium, LLC8$132
Impel Pharmaceuticals Inc.3$127
Medtronic3$117
Almatica Pharma LLC6$115
Azurity Pharmaceuticals, Inc.5$111
Aucta Pharmaceuticals, Inc.7$105
Sumitomo Pharma America, Inc.5$104
Arbor Pharmaceuticals, Inc.6$100
Averitas Pharma Inc.5$99
GRT US Holding, Inc.7$96
CSL Behring5$92
Scilex Pharmaceuticals Inc.5$91
Otsuka America Pharmaceutical, Inc.4$74

How this compares

$251,997 in reported general payments places this provider in the 90th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,215,033
Medicare patients
440
Services billed
50,078

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →